CLINICAL_TRIALS trial_result · 2022-04-14

Clinical Trial Update: Lipoprotein-associated Phospholipase A2 in Patients With Type 2 Diabetes

Clinical trial updating investigation of lipoprotein-associated phospholipase A2 in patients with type 2 diabetes has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Type2 Diabetes | Status: COMPLETED | Results posted: 2022-04-14